The use of biological variables to predict outcome in multiple myeloma

被引：14

作者：

Davies, FE ^{[1
]}

Jack, AS ^{[1
]}

Morgan, GJ ^{[1
]}

机构：

[1] Gen Infirm, Dept Haematol, Leeds LS1 3EX, W Yorkshire, England

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 1997年 / 99卷 / 04期

关键词：

multiple myeloma; prognosis; biological variables;

D O I：

10.1046/j.1365-2141.1997.3793193.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：719 / 725

页数：7

共 71 条

[1] Serum markers of bone metabolism in multiple myeloma: Prognostic value of the carboxy-terminal telopeptide of type I collagen (ICTP) [J].

Abildgaard, N ;

Bentzen, SM ;

Nielsen, JL ;

Heickendorff, L .

BRITISH JOURNAL OF HAEMATOLOGY, 1997, 96 (01) :103-110

[2] Development of an in vivo model of human multiple myeloma bone disease [J].

Alsina, M ;

Boyce, B ;

Devlin, RD ;

Anderson, JL ;

Craig, F ;

Mundy, GR ;

Roodman, GD .

BLOOD, 1996, 87 (04) :1495-1501

[3] EVIDENCE THAT THE CLONOGENIC CELL IN MULTIPLE-MYELOMA ORIGINATES FROM A PRE-SWITCHED BUT SOMATICALLY MUTATED B-CELL [J].

BAKKUS, MHC ;

VANRIET, I ;

VANCAMP, B ;

THIELEMANS, K .

BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (01) :68-74

[4] MECHANISMS OF BONE-LESIONS IN MULTIPLE-MYELOMA [J].

BATAILLE, R ;

CHAPPARD, D ;

KLEIN, B .

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1992, 6 (02) :285-295

[5] Quantifiable excess of bone resorption in monoclonal gammopathy is an early symptom of malignancy: A prospective study of 87 bone biopsies [J].

Bataille, R ;

Chappard, D ;

Basle, MF .

BLOOD, 1996, 87 (11) :4762-4769

[6] SERUM LEVELS OF INTERLEUKIN-6, A POTENT MYELOMA CELL-GROWTH FACTOR, AS A REFLECT OF DISEASE SEVERITY IN PLASMA-CELL DYSCRASIAS [J].

BATAILLE, R ;

JOURDAN, M ;

ZHANG, XG ;

KLEIN, B .

JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (06) :2008-2011

[7]

BATAILLE R, 1990, CANCER-AM CANCER SOC, V66, P167, DOI 10.1002/1097-0142(19900701)66:1<167::AID-CNCR2820660130>3.0.CO

[8]

2-9

[9] Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma [J].

Berenson, JR ;

Lichtenstein, A ;

Porter, L ;

Dimopoulos, MA ;

Bordoni, R ;

George, S ;

Lipton, A ;

Keller, A ;

Ballester, O ;

Kovacs, MJ ;

Blacklock, HA ;

Bell, R ;

Simeone, J ;

Reitsma, DJ ;

Heffernan, M ;

Seaman, J ;

Knight, RD .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) :488-493

[10] IN MULTIPLE-MYELOMA, CLONOTYPIC B-LYMPHOCYTES ARE DETECTABLE AMONG CD19(+) PERIPHERAL-BLOOD CELLS EXPRESSING CD38, CD56, AND MONOTYPIC IG LIGHT-CHAIN [J].

BERGSAGEL, PL ;

SMITH, AM ;

SZCZEPEK, A ;

MANT, MJ ;

BELCH, AR ;

PILARSKI, LM .

BLOOD, 1995, 85 (02) :436-447

← 1 2 3 4 5 6 7 8 →